MARKET

PROF

PROF

Profound Med Corp
NASDAQ
6.82
-0.08
-1.16%
Opening 12:12 05/29 EDT
OPEN
6.89
PREV CLOSE
6.90
HIGH
6.93
LOW
6.75
VOLUME
13.28K
TURNOVER
--
52 WEEK HIGH
8.95
52 WEEK LOW
3.760
MARKET CAP
247.82M
P/E (TTM)
-5.4608
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PROF last week (0518-0522)?
Weekly Report · 4d ago
Profound Medical (PRN) Receives a Buy from Lake Street
TipRanks · 05/18 15:05
Weekly Report: what happened at PROF last week (0511-0515)?
Weekly Report · 05/18 09:27
Profound Medical Shareholders Back Board, Question Incentive Plan
TipRanks · 05/15 20:53
Profound Medical announces annual and special shareholder meeting
PUBT · 05/15 20:12
Telix announces LoI to collaborate with EDAP TMS and Profound Medical
TipRanks · 05/15 10:40
Telix Pharma Enters Into LOI To Pursue Collaborations With EDAP And Profound Medical To Explore Investigational Use Of Telix's PSMA-PET1 Imaging Agents Gozellix And Illuccix With Robotic HIFU, And Other Image-Guided Therapies To Treat Prostate Cancer
Benzinga · 05/15 10:33
TELIX ANNOUNCES COLLABORATIONS TO EXPLORE PSMA-PET IMAGING IN EMERGING PROSTATE CANCER TREATMENT APPROACHES
Reuters · 05/15 10:30
More
About PROF
Profound Medical Corp. is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), AI-enhanced planning, robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low-, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

Webull offers Profound Medical Corp stock information, including NASDAQ: PROF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PROF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PROF stock methods without spending real money on the virtual paper trading platform.